John M. Wallmark
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Treatments and Studies 2
-
- Prostate Cancer Treatment and Research 2
- Advanced Breast Cancer Therapies 1
- Co-authors
- Sarina Anne Piha-Paul (5 shared papers)Samuel Ejadi (4 shared papers)Jean‐Pierre Delord (3 shared papers)Bhumsuk Keam (3 shared papers)Sanatan Saraf (3 shared papers)Aaron Richard Hansen (2 shared papers)Naomi Balzer Haas (2 shared papers)Christophe Massard (2 shared papers)
- Journals
- Annals of Oncology (3 papers)European Journal of Cancer (2 papers)Cancer Investigation (1 paper)PLoS ONE (1 paper)American Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
John M. Wallmark
10 papers receiving 873 citations
John M. Wallmark's Hit Papers
Peers
Comparison fields: 5 of 48
- Oncology 481
- Pulmonary and Respiratory Medicine 249
- Surgery 141
- Otorhinolaryngology 14
- Pathology and Forensic Medicine 39
Countries citing papers authored by John M. Wallmark
This map shows the geographic impact of John M. Wallmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Wallmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Wallmark more than expected).
Fields of papers citing papers by John M. Wallmark
This network shows the impact of papers produced by John M. Wallmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Wallmark. The network helps show where John M. Wallmark may publish in the future.
Co-authors
The 25 scholars most cited alongside John M. Wallmark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study Hit paper breakdown → | 2018 | 306 |
| 2 | 2017 | 241 | |
| 3 | 2018 | 167 | |
| 4 | 2021 | 63 | |
| 5 | 2016 | 40 | |
| 6 | 2012 | 37 | |
| 7 | Scleromyxedema: successful treatment of cutaneous and neurologic symptoms. | 2000 | 19 |
| 8 | 2015 | 16 | |
| 9 | 2019 | 4 | |
| 10 | Tamoxifen's impact on the management of breast cancer: the oncologist's perspective. | 1997 | 1 |
About John M. Wallmark
John M. Wallmark is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Geriatrics and Gerontology, Dermatology and Cancer Research, having authored 10 papers that have together received 894 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Prostate Cancer Treatment and Research (2 papers), Systemic Sclerosis and Related Diseases (1 paper), Salivary Gland Tumors Diagnosis and Treatment (1 paper), Advanced Breast Cancer Therapies (1 paper), Estrogen and related hormone effects (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Oncology (481 citations), Pulmonary and Respiratory Medicine (249 citations), Surgery (141 citations), Otorhinolaryngology (14 citations) and Pathology and Forensic Medicine (39 citations). John M. Wallmark has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Sarina Anne Piha-Paul, Samuel Ejadi, Jean‐Pierre Delord, Bhumsuk Keam, Sanatan Saraf, Aaron Richard Hansen, Naomi Balzer Haas, Christophe Massard, Patrick Alexander Ott and Juanita Suzanne Lopez. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Cancer Investigation, PLoS ONE and American Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.